February 2023
-
Valeo Pharma’s CEO Steve Saviuk Talks about Record FQ4 & F2022 Revenue Up 274% & 105%, Respectively
In this InvestorIntel interview, Tracy Weslosky talks to Valeo Pharma Inc.’s (TSX: VPH | OTCQB: VPHIF) Founder, CEO,…
-
Greg Fenton on ZenARMOR, Zentek’s novel corrosion protection technology
In this InvestorIntel interview, Tracy Weslosky talks to Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director Greg…
-
Greg Fenton on the impact of Zentek’s HVAC Phase 2 Testing results on Air Filtration
In this InvestorIntel interview, Tracy Weslosky talks to Zentek Ltd.‘s (NASDAQ: ZTEK | TSXV: ZEN) CEO and Director…
-
Decision Time: The Cheshire Cat Method or STEM for a Net Zero Carbon Future?
This is now Article 5 of the Net Zero Carbon series. In Articles 1 through 4 (“Net Zero…
-
Rare Earths, “The War Metals?”
Sometime after 2007, I was invited to participate in a meeting called by the Office of Net Threat…
-
Record revenues in 2022 of $27.7 million, Valeo Pharma investment in commercial infrastructure starts to pay off
What a difference a year makes. Last year at this time we were heading into wave something or…
-
It appears American Rare Earths has the right stuff
Last week I wrote an article about a rare earths explorer that had just announced a new President,…
-
Lining up uranium production, Ur-Energy responds to new sale agreements and rising demand
Uranium prices continue to drift higher as demand grows and supply remains both constrained and at risk of…
